NCT00001577View on ClinicalTrials.gov

Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

June 30, 1997

Study Completion Date

March 31, 2000

Conditions

MelanomaSarcoma

Interventions

PROCEDURE

double isolated limb perfusion with melphalan alone

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH